Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$137K
Net Open-Market Flow
-$137K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)6K$2.20$14K6K
Dec 17, 2025Sell(S)9K$7.04$60K0
Dec 17, 2025Option exercise(M)9K$2.50$21K9K
Dec 17, 2025Sell(S)6K$7.04$45K0
Dec 17, 2025Sell(S)4K$7.04$32K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)9K$050K
Dec 17, 2025Option exercise(M)6K$0102K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-25-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly: